Clinical Trial

Use of Blinded Tapering for Hypnotic Discontinuation

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The study will employ a randomized longitudinal clinical trial design to evaluate the relative efficacy of a blinded hypnotic tapering protocol when used in combination with therapist delivered Cognitive Behavioral Therapy for Insomnia (CBTI) for enhancing hypnotic discontinuation rates. A blinded SMT+CBTI intervention will be compared to open-label SMT+CBTI.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2019-08-07; most recent amendment 2025-02-20.
Status change: Suspended → Active, Not Recruiting 2023-11-03
Status change: Recruiting → Suspended 2021-04-30
Status change: Not Yet Recruiting → Recruiting 2020-02-24
Trial Details
NCT Number NCT04050176
Lead Sponsor National Jewish Health
Collaborators: National Institute on Drug Abuse (NIDA)
Conditions Hypnotic Dependence Among Those With Insomnia
Enrollment 260 participants
Start Date 2019-12-16
Primary Completion 2024-12-31 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-02-24